C07D 241/26
With nitrogen atoms directly attached to ring carbon atoms
Official title: with nitrogen atoms directly attached to ring carbon atoms
C07D241/26 (With nitrogen atoms directly attached to ring carbon atoms) appears on 307 US grants and 341 published applications in this corpus.
Search patents in C07D- Granted patents
- 307
- Published applications
- 341
- Assignees
- 134
- Inventors
- 860
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 7 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 5 |
| 2003 | 5 | 8 |
| 2004 | 5 | 18 |
| 2005 | 5 | 16 |
| 2006 | 7 | 15 |
| 2007 | 12 | 10 |
| 2008 | 13 | 14 |
| 2009 | 5 | 14 |
| 2010 | 6 | 15 |
| 2011 | 7 | 11 |
| 2012 | 16 | 16 |
| 2013 | 11 | 12 |
| 2014 | 17 | 24 |
| 2015 | 17 | 22 |
| 2016 | 10 | 10 |
| 2017 | 12 | 22 |
| 2018 | 20 | 10 |
| 2019 | 15 | 17 |
| 2020 | 6 | 7 |
| 2021 | 6 | 12 |
| 2022 | 6 | 15 |
| 2023 | 9 | 18 |
| 2024 | 5 | 11 |
| 2025 | 9 | 12 |
| 2026 | 8 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof28 Jul 2026US 12,692,240 B2MediBeacon Inc.
- Pyrazinecarboxamide analog compounds for use in treating cancer16 Jun 2026US 12,655,131 B2
- Carbonohydrazonoyl dicyanide compounds comprising 2 or more aryl or heteroaryl connected via linker and use thereof9 Jun 2026US 12,649,723 B2Korea Institute of Science and Technology
- Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof26 May 2026US 12,637,435 B2FUJIFILM Corporation
- Inhibitors of SARM17 Apr 2026US 12,595,252 B2Disarm Therapeutics, Inc.
- Pyrazinecarboxamide analog compounds for use in treating cancer1 Oct 2026US 2026/0297064 A1Novapano LLC
- Gpr35 modulators30 Jul 2026US 2026/0216198 A1ThirtyFiveBio Limited
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Neutrophil elastase inhibitor and use thereof16 Jul 2026US 2026/0200845 A1Shanghai Yidi Biotechnology Co., Ltd
- Mixed mode charge induction ion exchange (iex) chromatography (mmciic) ligands and methods of use28 May 2026US 2026/0145159 A1Bio-Rad Laboratories, Inc.
Most cited
By later US patents
- Pyridine and pyrazine derivative for the treatment of CF76US 8,247,436 B2Novartis AG · 2012
- Phenolic guanidine sodium channel blockers69US 6,858,614 B2Parion Sciences, Inc. · 2005
- Phenyl guanidine sodium channel blockers69US 6,858,615 B2Parion Sciences, Inc. · 2005
- Sodium channel blockers64US 6,903,105 B2Parion Sciences, Inc. · 2005
- Substituted aryl 1,4-pyrazine derivatives61US 6,992,087 B2Pfizer Inc. · 2006